[Federal Register Volume 64, Number 18 (Thursday, January 28, 1999)]
[Notices]
[Pages 4455-4456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-1965]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Cancer Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board.
Date: February 8-10, 1999.
Name of Committee: National Cancer Advisory Board, Subcommittee
on Cancer Centers.
Open: February 8, 1999, 7:00 pm to 8:30 pm.
Agenda: To discuss NCI Cancer Centers policies.
Place: The Hyatt Regency Hotel, 100 Bethesda Metro Center,
Susquehana Severn Room, Bethesda, MD 20892.
Contact Person: Brian Kimes, Executive Secretary, Office of
Centers, Training, and Resources, National Cancer Institute,
National Institutes of Health, Executive Plaza North--Suite 502,
6130 Executive Boulevard, Rockville, MD 20892, (301) 496-8537.
Name of Committee: National Cancer Advisory Board, Subcommittee
on Planning and Budget.
Open: February 9, 1999, 12:10 pm to 1:30 pm.
Agenda: To discuss the current and future initiatives of the NCI
Bypass Budget.
Place: Building 31, C Wing, 6 Floor, Conference Room 10,
National Institutes of Health, 3100 Center Drive, Bethesda, MD
20892.
Contact Person: Ms. Cherie Nichols, Executive Secretary, Office
of Science Policy, National Cancer Institute, National Institutes of
Health, Building 31, Room 11A03, 3100 Center Drive, Bethesda, MD
20892, (301) 496 -5515.
Name of Committee: National Cancer Advisory Board.
Open: February 9, 1999, 9:00 am to 4:00 pm.
Agenda: Introductions and Welcome to New Members; Reports from
NCI Director, President's Cancer Panel, American Association for
Cancer Research, A110 and FOIA; Annual Delegation of Authority;
Update on Geographic Patterns of Cancer Mortality in the U.S.;
Legislative Update, and Cancer Surveillance Series Surveillance
Implementation Group Report.
Place: Building 31, C Wing, 6 Floor, Conference Room 10,
National Institutes of Health, 3100 Center Drive, Bethesda, MD
20892.
Closed: February 9, 1999, 4:15 pm to Adjournment.
Agenda: To review and discuss grant applications.
Place: Building 31, C Wing, 6 Floor, Conference Room 10,
National Institutes of Health, 3100 Center Drive, Bethesda, MD
20892.
Open: February 10, 1999, 9:00 am to 12:05 pm.
Agenda: Annual Report on Gender and Minority Accrual to Clinical
Trials; Update on Programs for Underserved Populations; Office of
Cancer Complimentary and Alternative Medicine; Subcommittee Reports,
New Business; and Future Agenda Items.
Place: Building 31, C Wing, 6 Floor, Conference Room 10,
National Institutes of Health, 3100 Center Drive, Bethesda, MD
20892.
Contact Person: Marvin R. Kalt, Executive Secretary, Division of
Extramural Activities, National Cancer Institute, National
Institutes of Health, Executive Plaza North, Suite 600, 6130
Executive Boulevard, Rockville, MD 20892, (301) 496-5147.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
[[Page 4456]]
Dated: January 22, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-1965 Filed 1-27-99; 8:45 am]
BILLING CODE 4140-01-M
